Novel and next-generation androgen receptor–directed therapies for prostate cancer: Beyond abiraterone and enzalutamide

Published 2016 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Novel and next-generation androgen receptor–directed therapies for prostate cancer: Beyond abiraterone and enzalutamide
Authors
Keywords
Castration-resistant prostate cancer, Galeterone, VT-464, ARN-509, ODM-201, Bipolar androgen therapy
Journal
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Volume 34, Issue 8, Pages 348-355
Publisher
Elsevier BV
Online
2015-07-08
DOI
10.1016/j.urolonc.2015.05.025

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.